vs

Side-by-side financial comparison of Core Scientific, Inc. (CORZ) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $79.8M, roughly 1.2× Core Scientific, Inc.). Core Scientific, Inc. runs the higher net margin — 268.5% vs 25.0%, a 243.5% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -16.0%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-450.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -33.3%).

Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

CORZ vs VCEL — Head-to-Head

Bigger by revenue
VCEL
VCEL
1.2× larger
VCEL
$92.9M
$79.8M
CORZ
Growing faster (revenue YoY)
VCEL
VCEL
+39.2% gap
VCEL
23.3%
-16.0%
CORZ
Higher net margin
CORZ
CORZ
243.5% more per $
CORZ
268.5%
25.0%
VCEL
More free cash flow
VCEL
VCEL
$463.6M more FCF
VCEL
$12.8M
$-450.8M
CORZ
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
-33.3%
CORZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORZ
CORZ
VCEL
VCEL
Revenue
$79.8M
$92.9M
Net Profit
$214.2M
$23.2M
Gross Margin
26.0%
78.7%
Operating Margin
-149.5%
24.1%
Net Margin
268.5%
25.0%
Revenue YoY
-16.0%
23.3%
Net Profit YoY
180.6%
17.3%
EPS (diluted)
$-1.63
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORZ
CORZ
VCEL
VCEL
Q4 25
$79.8M
$92.9M
Q3 25
$81.1M
$67.5M
Q2 25
$78.6M
$63.2M
Q1 25
$79.5M
$52.6M
Q4 24
$94.9M
$75.4M
Q3 24
$95.4M
$57.9M
Q2 24
$141.1M
$52.7M
Q1 24
$179.3M
$51.3M
Net Profit
CORZ
CORZ
VCEL
VCEL
Q4 25
$214.2M
$23.2M
Q3 25
$-144.0M
$5.1M
Q2 25
$-936.8M
$-553.0K
Q1 25
$576.3M
$-11.2M
Q4 24
$-265.5M
$19.8M
Q3 24
$-455.3M
$-901.0K
Q2 24
$-902.2M
$-4.7M
Q1 24
$210.7M
$-3.9M
Gross Margin
CORZ
CORZ
VCEL
VCEL
Q4 25
26.0%
78.7%
Q3 25
4.8%
73.5%
Q2 25
6.4%
73.7%
Q1 25
10.3%
69.0%
Q4 24
5.0%
77.6%
Q3 24
-0.2%
71.9%
Q2 24
27.5%
69.5%
Q1 24
43.3%
68.9%
Operating Margin
CORZ
CORZ
VCEL
VCEL
Q4 25
-149.5%
24.1%
Q3 25
-67.6%
5.1%
Q2 25
-33.4%
-3.2%
Q1 25
-59.1%
-24.3%
Q4 24
-41.9%
24.5%
Q3 24
-43.2%
-4.3%
Q2 24
-64.3%
-11.5%
Q1 24
30.8%
-10.7%
Net Margin
CORZ
CORZ
VCEL
VCEL
Q4 25
268.5%
25.0%
Q3 25
-177.6%
7.5%
Q2 25
-1191.4%
-0.9%
Q1 25
724.6%
-21.4%
Q4 24
-279.7%
26.3%
Q3 24
-477.4%
-1.6%
Q2 24
-639.4%
-8.9%
Q1 24
117.5%
-7.5%
EPS (diluted)
CORZ
CORZ
VCEL
VCEL
Q4 25
$-1.63
$0.46
Q3 25
$-0.45
$0.10
Q2 25
$-0.04
$-0.01
Q1 25
$1.24
$-0.23
Q4 24
$0.51
$0.40
Q3 24
$-1.17
$-0.02
Q2 24
$-5.05
$-0.10
Q1 24
$0.78
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORZ
CORZ
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$311.4M
$137.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-962.7M
$354.6M
Total Assets
$2.3B
$488.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORZ
CORZ
VCEL
VCEL
Q4 25
$311.4M
$137.5M
Q3 25
$453.4M
$135.4M
Q2 25
$581.3M
$116.9M
Q1 25
$697.9M
$112.9M
Q4 24
$836.2M
$116.2M
Q3 24
$253.0M
$101.7M
Q2 24
$96.1M
$102.5M
Q1 24
$98.1M
$110.6M
Stockholders' Equity
CORZ
CORZ
VCEL
VCEL
Q4 25
$-962.7M
$354.6M
Q3 25
$-1.3B
$321.9M
Q2 25
$-1.2B
$306.8M
Q1 25
$-308.8M
$295.5M
Q4 24
$-943.0M
$292.0M
Q3 24
$-826.7M
$257.5M
Q2 24
$-1.2B
$243.0M
Q1 24
$-318.5M
$233.9M
Total Assets
CORZ
CORZ
VCEL
VCEL
Q4 25
$2.3B
$488.0M
Q3 25
$2.2B
$453.3M
Q2 25
$1.9B
$435.6M
Q1 25
$1.5B
$424.6M
Q4 24
$1.5B
$432.7M
Q3 24
$824.6M
$390.4M
Q2 24
$664.2M
$376.8M
Q1 24
$814.0M
$356.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORZ
CORZ
VCEL
VCEL
Operating Cash FlowLast quarter
$278.3M
$15.0M
Free Cash FlowOCF − Capex
$-450.8M
$12.8M
FCF MarginFCF / Revenue
-565.1%
13.8%
Capex IntensityCapex / Revenue
914.0%
2.4%
Cash ConversionOCF / Net Profit
1.30×
0.65×
TTM Free Cash FlowTrailing 4 quarters
$-779.8M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORZ
CORZ
VCEL
VCEL
Q4 25
$278.3M
$15.0M
Q3 25
$131.8M
$22.1M
Q2 25
$34.0M
$8.2M
Q1 25
$-45.0M
$6.6M
Q4 24
$42.9M
$22.2M
Q3 24
$5.7M
$10.2M
Q2 24
$1.2M
$18.5M
Q1 24
$22.2M
$7.2M
Free Cash Flow
CORZ
CORZ
VCEL
VCEL
Q4 25
$-450.8M
$12.8M
Q3 25
$-112.7M
$19.5M
Q2 25
$-87.3M
$81.0K
Q1 25
$-129.0M
$-7.6M
Q4 24
$-52.1M
$8.5M
Q3 24
$-25.5M
$-9.2M
Q2 24
$-1.9M
$1.8M
Q1 24
$-9.7M
$-6.8M
FCF Margin
CORZ
CORZ
VCEL
VCEL
Q4 25
-565.1%
13.8%
Q3 25
-139.0%
28.8%
Q2 25
-111.0%
0.1%
Q1 25
-162.2%
-14.5%
Q4 24
-54.8%
11.2%
Q3 24
-26.7%
-15.9%
Q2 24
-1.4%
3.4%
Q1 24
-5.4%
-13.3%
Capex Intensity
CORZ
CORZ
VCEL
VCEL
Q4 25
914.0%
2.4%
Q3 25
301.5%
3.9%
Q2 25
154.2%
12.9%
Q1 25
105.6%
27.0%
Q4 24
100.0%
18.3%
Q3 24
32.7%
33.5%
Q2 24
2.2%
31.8%
Q1 24
17.8%
27.3%
Cash Conversion
CORZ
CORZ
VCEL
VCEL
Q4 25
1.30×
0.65×
Q3 25
4.35×
Q2 25
Q1 25
-0.08×
Q4 24
1.12×
Q3 24
Q2 24
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORZ
CORZ

Other$36.3M46%
Digital Asset Self Mining Service$31.8M40%
Colocation Service$11.6M15%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons